Cancer Forums and News by PhD's


News | Forums Register

Go Back   Cancer Forums and News by PhD's > Breast Cancer Forum

 
 
Thread Tools Display Modes
Prev Previous Post   Next Post Next
  #1  
Old 07-08-2013, 01:44 PM
Dross Dross is offline
Moderator
 
Join Date: Nov 2006
Posts: 883
Default New target combined with Tamoxifen aids in ER-positive breast cancers

Researchers have identified compounds used in some leukemia treatments that may have an application towards ER positive breast cancer that is unresponsive to traditional treatments.

The discovery was made at the Walter and Eliza Hall Institute. BH3-mimetics were effective in treating aggressive oestrogen receptor-positive breast cancers when combined with the breast cancer drug tamoxifen in preclinical models. Approximately 70 per cent of breast cancers are ER positive.

"Drs Vaillant and Merino looked at the effect of adding BH3-mimetics to the standard hormone treatment, tamoxifen, used for a subtype of ER-positive cancers called luminal B cancers, which had high levels of BCL-2," said Professor Lindeman . "They found that a BH3-mimetic called ABT-199/GDC-0199 improved the effectiveness of hormone therapy by stopping or delaying the growth of these aggressive tumours. In one of the tumour models, the combined treatment caused complete disappearance of the tumour, while standard treatment had only a partial and unsustained benefit."

The new target, BCL-2, is responsible for suppressing a cancer cells desire to apoptose, or kill itself.

Read more: [url]http://www.cell.com/cancer-cell/abstract/S1535-6108(13)00282-1

Last edited by gdpawel : 07-15-2013 at 09:15 AM. Reason: posted full article in forum board
Reply With Quote
 


Thread Tools
Display Modes

Posting Rules
You may not post new threads
You may not post replies
You may not post attachments
You may not edit your posts

vB code is On
Smilies are On
[IMG] code is On
HTML code is Off
Forum Jump


All times are GMT -5. The time now is 08:05 PM.